Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 22;63(20):11707-11724.
doi: 10.1021/acs.jmedchem.0c00856. Epub 2020 Oct 2.

Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates _targeting Biofilm-Associated Lectins of Pseudomonas aeruginosa

Joscha Meiers  1   2   3 , Eva Zahorska  1   2   3 , Teresa Röhrig  2   4 , Dirk Hauck  1   2 , Stefanie Wagner  1   2 , Alexander Titz  1   2   3
Affiliations

Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates _targeting Biofilm-Associated Lectins of Pseudomonas aeruginosa

Joscha Meiers et al. J Med Chem. .

Abstract

Chronic infections by Pseudomonas aeruginosa are characterized by biofilm formation, which effectively enhances resistance toward antibiotics. Biofilm-specific antibiotic delivery could locally increase drug concentration to break antimicrobial resistance and reduce the drug's peripheral side effects. Two extracellular P. aeruginosa lectins, LecA and LecB, are essential structural components for biofilm formation and thus render a possible anchor for biofilm-_targeted drug delivery. The standard-of-care drug ciprofloxacin suffers from severe systemic side effects and was therefore chosen for this approach. We synthesized several ciprofloxacin-carbohydrate conjugates and established a structure-activity relationship. Conjugation of ciprofloxacin to lectin probes enabled biofilm accumulation in vitro, reduced the antibiotic's cytotoxicity, but also reduced its antibiotic activity against planktonic cells due to a reduced cell permeability and on _target activity. This work defines the starting point for new biofilm/lectin-_targeted drugs to modulate antibiotic properties and ultimately break antimicrobial resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
The lectin inhibitors 1 and 2 are conjugated to the antibiotic ciprofloxacin (3) resulting in pathogen-specific, lectin-_targeted antibiotics. These compounds _target the biofilm-associated lectins LecA and LecB and therefore increase local antibiotic concentration at the site of infection, resulting in fewer side effects caused by unspecific distribution and tissue accumulation. Blue arrows display growth vectors used in this work.
Scheme 1
Scheme 1. Chemical Synthesis of the (A) LecA-_targeting (11–14) and (B) LecB-_targeting (19) Probes and (C) Alkyne Ciprofloxacin Derivatives 20 and 21
Reagents and conditions: (a) p-nitrothiophenol, BF3·Et2O, CH2Cl2, 0 °C to r.t., 16 h; (b) H2, Pd/C, CH2Cl2, r.t., 24 h; (c) (i) Br(CH2)nCOHal, Et3N, or K2CO3, DMF, 0 °C to r.t., 1–4 h, (ii) NaN3, DMF, r.t., 4 h; (d) cat. NaOMe, MeOH, r.t., 1 h; (e) (i) PBr3, CH2Cl2, 0 °C to r.t., 1 h, (ii) HSO3Cl, CH2Cl2, 0 °C to r.t., 3 h; (f) crude 16, K2CO3, DMF, r.t., 5 h; (g) NaN3, DMF, r.t., 5 h; (h) propargylbromide or 4-bromo-but-1-yne, Et3N, DMF, 70 °C, 1–4 d.
Scheme 2
Scheme 2. Assembly of the Lectin-_targeted Ciprofloxacin Conjugates
Reagents and conditions: (a) cat. CuSO4, cat. sodium ascorbate, DMF/H2O, r.t. 16 h, r.t. (for 11–14) or 40 °C (for 19).
Figure 2
Figure 2
Competitive binding assay of lectin-_targeted ciprofloxacin conjugates 22–31, lectin probes 11–14 and 19, and control compounds with LecA, LecBPAO1, and LecBPA14. One representative titration of triplicates on one plate is shown for each compound (IC50 in Table 1 and Ki in Table S1).
Figure 3
Figure 3
Effect of 20, 22, 23, 30, and ciprofloxacin (3) on gyrase-catalyzed DNA supercoiling. Propargylation (20) decreased the inhibitory concentration only by a factor of 3.5 compared to 3. Gyrase inhibition as a putative mode of action was confirmed as all conjugates inhibit gyrase-catalyzed DNA supercoiling. Mean and standard deviations were determined from three independent experiments. A representative titration of E. coli gyrase with 22 in a supercoiling inhibition assay is shown. Controls: plasmid without gyrase and inhibitor (leftmost band) and plasmid with gyrase and without inhibitor (rightmost band). ON, open circular/nicked plasmid; R, relaxed topoisomers; SC, supercoiled topoisomers of E. coli DNA.
Figure 4
Figure 4
Accumulation of 22 (_targeting LecA) and 30 (_targeting LecB) in P. aeruginosa PAO1 biofilm relative to ciprofloxacin (3). Each data point reflects the relative accumulation compared to ciprofloxacin of a single independent assay with at least three technical replicates. Bars show geometric mean and 95% confidence interval (see the Supporting Information for more detailed information, Figure S2).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rice L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 2008, 197, 1079–1081. 10.1086/533452. - DOI - PubMed
    1. Boucher H. W.; Talbot G. H.; Bradley J. S.; Edwards J. E.; Gilbert D.; Rice L. B.; Scheld M.; Spellberg B.; Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48, 1–12. 10.1086/595011. - DOI - PubMed
    1. Rice L. B. Progress and challenges in implementing the research on ESKAPE pathogens. Infect. Control Hosp. Epidemiol. 2010, 31, S7–S10. 10.1086/655995. - DOI - PubMed
    1. Meynard J.-L.; Barbut F.; Guiguet M.; Batissel D.; Lalande V.; Lesage D.; Guiard-Schmid J.-B.; Petit J.-C.; Frottier J.; Meyohas M.-C. Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J. Infect. 1999, 38, 176–181. 10.1016/S0163-4453(99)90247-5. - DOI - PubMed
    1. Rizzi E. B.; Schininà V.; Bordi E.; Buontempo G.; Narciso P.; Bibbolino C. HIV-related bronchopulmonary infection by pseudomonas aeruginosa in the HAART era: radiological findings. Acta Radiol. 2006, 47, 793–797. 10.1080/02841850600827569. - DOI - PubMed

Publication types

MeSH terms

  NODES
Bugs 4
twitter 2